                         SEQUENCE LISTING

<110>  The University of British Columbia
 
<120>  COMBINATION THERAPY FOR CANCER USING HSP27 INHIBITOR AND EGFR 
       TYROSINE KINASE INHIBITORS OR ANTI-FOLATES

<130>  UBC.P-054-WO

<150>  US 61/594,173
<151>  2012-02-02

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  antisense of human hsp27


<220>
<221>  modified_base
<222>  (5)..(5)
<223>  m5c

<220>
<221>  modified_base
<222>  (7)..(7)
<223>  m5c

<220>
<221>  modified_base
<222>  (10)..(10)
<223>  m5c

<220>
<221>  modified_base
<222>  (12)..(12)
<223>  m5c

<220>
<221>  modified_base
<222>  (14)..(14)
<223>  m5c

<220>
<221>  modified_base
<222>  (17)..(17)
<223>  mo5u

<220>
<221>  modified_base
<222>  (18)..(18)
<223>  m5c

<220>
<221>  modified_base
<222>  (20)..(20)
<223>  mo5u

<400>  1
gggacgcggc gctcggucau                                                   20


<210>  2
<211>  19
<212>  RNA
<213>  homo sapiens

<400>  2
gcugcaaaau ccgau gaga                                              19


<210>  3
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  scrambled control

<400>  3
cagcgcugac aacaguuucau                                                   21


